Harvoni registers its name in the pharmaceutical patent list
Harvoni Tab(sofosbuvir, ledipasvir), a hepatitis C treatment, register its name in the pharmaceutical patent list.
In the Ministry of Food and Drug Safety’s ‘Pharmaceutical Patent List,’ Gilead Sciences Korea was known to register the two products of Harvoni Tab on the 20th.
The two products’ r...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
